Posterior Scleral Reinforcement Combined with Patching Therapy for Pre-School Children with Unilateral High Myopia

Zhao-Meng Shen,Zhen-Yong Zhang,Lin-Yi Zhang,Zhi-Guo Li,Ren-Yuan Chu

DOI: https://doi.org/10.1007/s00417-015-2963-9

2015-01-01

Abstract:Our purpose was to investigate the effect of posterior scleral reinforcement (PSR) combined with patching therapy for pre-school children with unilateral high myopia.

What problem does this paper attempt to address?

The efficacy of modified posterior scleral reinforcement with round scleral patches in Chinese children with high myopia

Xuran Dong,Jing Liu,Juan Bu

DOI: https://doi.org/10.1007/s00417-020-04646-3

2020-01-01

Abstract:Purpose To observe the efficacy of modified Snyder-Thompson posterior scleral reinforcement with round scleral patches in Chinese children with high myopia. Methods This retrospective study included 46 Chinese children with high myopia (72 eyes) who underwent modified Snyder-Thompson posterior scleral reinforcement (PSR) with round scleral patches and 43 Chinese children with high myopia (67 eyes) who wore only spectacles as a control group. Both groups attended a follow-up at 3 years. Axial length (AL), spherical equivalent (SE), best-corrected visual acuity (BCVA), and full ocular assessment results were evaluated at the initial and final visits. Complications were recorded. Results AL had increased by 0.29 ± 0.33 mm in the PSR group and 0.82 ± 0.33 mm in the control group ( P < 0.0001) at the final follow-up. The change in the SE was 0.31 ± 0.81 D in the PSR group and 2.25 ± 1.02 D in the control group ( P < 0.0001). A decrease of 0.02 ± 0.11 LogMAR was found in the control group, and a change of 0.22 ± 0.35 LogMAR was found in the PSR group. No serious complications due to PSR surgery occurred. Conclusions Modified Snyder-Thompson PSR surgery with round scleral patches can effectively limit the progression of axial elongation in Chinese children with high myopia. The operation is safe, causes little damage, and can be customized.
Efficacy of Posterior Scleral Reinforcement in Treating Anisometropic Amblyopia Associated With Unilateral High Myopia in Children

Fang Yu,Yu Tang,Zhihong Lin,Zhengyang Tao,Hongwei Deng

DOI: https://doi.org/10.1097/scs.0000000000010792

2024-10-19

Journal of Craniofacial Surgery

Abstract:The aim of this study is to examine the effectiveness and safety of posterior scleral reinforcement (PSR) for treating anisometropic amblyopia and myopia associated with high myopia in children. Children with unilateral high myopia (uHM) and anisometropic amblyopia who underwent PSR in their highly myopic eyes were included in this study. The treated eye was designated as the PSR group, whereas the healthier eye served as the control, and paired comparisons were made. Thirteen patients (13 eyes in each group) were included, with an average age of 5.85±2.08 years. Cross-sectional comparisons between the groups showed that within 2 to 3 years after surgery, the PSR group had a significantly greater increase in best-corrected visual acuity per month compared with the control group ( P =0.03), a significantly lower increase in axial length per month ( P =0.007), and a significantly smaller absolute value of the increase in SE per month ( P =0.002). Temporal longitudinal comparisons within the PSR group indicated that the increase in axial length per month 2 to 3 years after surgery was significantly slower than 1 year before surgery ( P =0.045). The increase in best-corrected visual acuity per month was higher than 1 year before surgery, although not significantly ( P =0.859). PSR is a safe and effective treatment for refractory anisometropic amblyopia caused by uHM, and for controlling axial length and the degree of myopia.

surgery
Modified Posterior Scleral Reinforcement As a Treatment for High Myopia in Children and Its Therapeutic Effect

Zequn Miao,Luojia Li,Xiaoli Meng,Lili Guo,Di Cao,Yanlei Jia,Dongmei He,Lvzhen Huang,Lejin Wang

DOI: https://doi.org/10.1155/2019/5185780

2019-01-01

BioMed Research International

Abstract:Purpose To investigate the safety and therapeutic effect of a modified posterior scleral reinforcement (PSR) in treating high myopia. Methods A total of 85 highly myopic eyes in 47 children (6.3±3.6 years of age, range from 3 years to 15 years) who underwent this modified PSR were included in this study. Axial length, refractive error, best-corrected visual acuity (BCVA), macular scans, and adverse events were recorded before the operation (as a baseline) and in postoperative reviews taken yearly for 5 years. Results This was a 5-year research: 50% of the children (20 children, 40 eyes) participated in the 6-month review, 41% of the children (17 children, 33 eyes) participated in the 1-year review, 26% of the children (11 children, 21 eyes) participated in the 2-year review, 16% of the children (7 children, 13 eyes) participated in the 3-year review, 13% of the children (5.3 children, 11 eyes) participated in the 4-year review, and 8% of the children (3.3 children, 7 eyes) participated in the 5-year review. Compared with the baseline, axial elongation was significantly changed (P<0.05) over the 5-year period in all of the children: 6-month (P=0.003), 1-year (P=0), 2-year (P=0), 3-year (P=0), 4-year (P=0), and 5-year (P=0). The axial length was extended. No significant difference was found in refractive error between measurements taken at baseline and at the 5-year postoperative visit in all of the children: 6-month (P=0.51), 1-year (P=0.50), 2-year (P=0.46), 3-year (P=0.56), 4-year (P=0.30), and 5-year (P=0.16). There were significant differences in BCVA between measurements taken at baseline and at the postoperative 5-year visit in all the children: 6-month (P=0), 1-year (P=0), 2-year (P=0), 3-year (P=0), 4-year (P=0), and 5-year (P=0). BCVA improved in 71 eyes (83.52%), remained stable in 14 eyes (16.47%), and declined in none of the children. No serious adverse events occurred before the operation and during the 5-year follow-up period. Conclusion This modified PSR could be a therapeutic treatment for high myopia.
Clinical outcomes of posterior scleral reinforcement in Chinese high myopia children

Haiyun Ye,Ruizhi Tang,Wangyi Fang,Yue Di,Tong Qiao

DOI: https://doi.org/10.1038/s41598-024-67078-7

2024-07-17

Abstract:We aim to observe the posterior scleral reinforcement (PSR) clinical outcomes of children with high myopia and analyze the retinal vessel alteration before and after PSR by using angiography optical coherence tomography (angio-OCT). Fifty-six pediatric participants (112 eyes) clinically diagnosed high myopia were recruited and were treated by PSR in Shanghai Children's Hospital from June 1, 2021 to May 1, 2023. The average age ranged from 5.42 to 14.83 years (mean 8.83 years) and mean follow up duration was 8.7 months (3-24 months). The axial length (AL) was significantly shortened after PSR (p < 0.05). The spherical equivalent (SE) and the best-corrected visual acuity (BCVA) were also improved without severe rejection in the follow-up. Compared with baseline, angio-OCT parafoveal vessel indices including vascular area density (VAD) and vascular skeleton density (VSD) on the superficial capillary plexus layer (SCPL), as well as VAD and vessel perimeter index (VPI) on the deep capillary plexus layer (DCPL), were significantly increased after PSR surgery (p < 0.05). VPI on the SCPL, vascular diameter index (VDI) and VSD on the DCPL were also improved without statistical difference after PSR. The VSD on SCPL, VAD on DCPL of the right eyes and the VPI on SCPL of the left eyes were significantly increased after PSR (p < 0.05). PSR surgery can shorten the AL and can stable BCVA and SE in high myopia children. The angio-OCT parameters indicated that the retinal microcirculation supply was significantly improved after PSR.
The Efficacy and Safety of Modified Snyder–Thompson Posterior Scleral Reinforcement in Extensive High Myopia of Chinese Children

Minjie Chen,Jinhui Dai,Renyuan Chu,Yifeng Qian

DOI: https://doi.org/10.1007/s00417-013-2429-x

2013-01-01

Abstract:To observe the efficacy and safety of modified Snyder–Thompson posterior scleral reinforcement in extensive high myopia of Chinese children. We had a retrospective design, and included a control group of children with natural progression of high myopia.
Curative effects of posterior scleral reinforce-ment in high myopic patients with macular retinoschisis

ZHU Zi-Cheng,ZHANG Jin-Song,KE Gen-Jie

DOI: https://doi.org/10.13389/j.cnki.rao.2009.06.018

2009-01-01

Abstract:Objective To investigate the effects of modified posterior sclera reinforcement in high myopic eyes with macular retinoschisis,and to explore the optimal therapeutic prescription.Methods Twenty-four cases(24 eyes) with high myopia and secondary macular retinoschisis were treated with improved posterior scleral reinforcement.Changes of pre- and post-operative visual field,results of optical coherence tomography(OCT),best corrected visual acuity(BCVA),diopter and ophthalmological A- or B-mode ultrasonography were analyzed.Results OCT showed that macular schizocoel disappeared in 20 eyes,and only 1 eye developed to macular hole at 1 year postoperatively.The average length of axis oculi was(30.89±0.36)mm preoperatively and(29.53±0.33)mm postoperatively in 23 eyes(t=12.716,P=0.000);The central visual field improved in 18 eyes,and remained steadily in 5 eyes.Preoperative and postoperative central visval field were 17.23 dB to 20.67 dB,23.12 dB to 27.63 dB,respectively.There was significant difference between them(χ2=16.872,P<0.05).The postoperative BCVA improved by 2 lines or more was in 18 eyes,and remained steadily in 5 eyes.Postoperative diopter declined in 23 eyes compared with that postoperatively(t=3.527,P=0.002).Conclusion The improved posterior scleral reinforcement is effective to treat high myopic patients with macular retinoschisis,and can improve visual acuity and prevent the degeneration of disease.
Effect and safety posterior scleral reinforcement on controlling myopia in children: a meta-analysis

Deng, Hongwei

DOI: https://doi.org/10.1007/s10792-024-02929-w

IF: 2.029

2024-02-07

International Ophthalmology

Abstract:The aim of this meta-analysis was to assess the efficacy of posterior scleral reinforcement (PSR) on the control of pediatric myopia. Electronic databases were systematically searched.

ophthalmology
Posterior Scleral Reinforcement in the Treatment of Macular Retinoschisis in Highly Myopic Patients

Zicheng Zhu,Xueying Ji,Jinsong Zhang,Genjie Ke

DOI: https://doi.org/10.1111/j.1442-9071.2009.02111.x

2009-01-01

Abstract:AbstractThe objective of this study was to evaluate the clinical curative effect of posterior scleral reinforcement for macular retinoschisis in highly myopic patients. Twenty‐four highly myopic eyes with macular retinoschisis were treated with posterior scleral reinforcement surgery from September 2005 to March 2007 in our hospital. Visual field, best corrected vision acuity (BCVA), refractive error, optical coherence tomography and A/B Scan ultrasound graphy results were retrospectively analysed. The central visual field in 18 eyes was improved after surgery; optical coherence tomography showed complete resolution of the myopic foveoschisis in 20 (83.33%) of the 24 eyes after surgery. The postoperative BCVA was improved by 0.1 or more in 18 eyes (75%), and remained within 0.1 of the preoperative BCVA in five eyes (20.83%) at the end of follow‐up. Compared with the preoperative data of 23 eyes, the final magnitude of myopia after surgery was significantly decreased (t = 3.527, P = 0.002). In conclusion, this procedure can effectively treat highly myopic patients with macular retinoschisis without macular hole or retinal detachment, and might be better for maintaining central vision and preventing the occurrence of complications.
Security and validity of posterior sclera reinforcement for high myopic retinopathy

Xiu WANG,Qing HE,Xiao-Xiao LU,An-Quan XUE,Rui-Hua WEI

DOI: https://doi.org/10.13389/j.cnki.rao.2018.0010

2018-01-01

Abstract:Objective To investigate the efficacy of security and validity of posterior sclera reinforcement (PSR) for high myopic retinopathy (MR).Methods This study included 76 eyes in 41 patients with MR who underwent PSR and were followed up for two years.Preoperative and postoperative axial length,best-corrected visual acuity,the reattachment of retinoschisis and the complications were evaluated.Results The axial length was shortened 3 days,1 month,3 months and 6 months after operation compared with preoperation[(27.71 ± 1.60) mm,(28.11 ± 1.62) mm,(28.58 ± 1.80)mm and (29.01 ± 1.92) mm vs.(30.29 ± 2.01) mm],and the difference was statistically significant (all P =0.000).The axial length gradually increased to preoperative level at 1 year after surgery,and there was no significant difference in the postoperative 2-year and preoperative axial length (P =0.300).The best corrected visual acuity was improved 1 month after surgery,but the improvement had no significantly difference compared with the preoperative one (P =0.080).The best corrected visual acuity was improved at 3 months,6 months,1 year and 2 years postoperatively continuously,and the improvement had significantly difference compared with the preoperative ones (all P ＜0.05).In addition,there were 34 eyes with retinoschisis before surgery,and the retina was completely attached postoperatively in 27 eyes (79.41％),almost attachment was observed in 4 eyes (11.76％),and improvement was in 3 eyes (8.82％).No complications occurred during surgery.Conjunctival irritation,high intraocuiar pressure,orbital inflammation,diplopia and visual deformation and macular bleeding recurrence occurred postoperatively and all recovered in 3 months.Conclusion During 2-year follow-up,it is safe and effective for PSR to treat MR,which can control myopic progression effectively in patients with pathological myopia.
The effectiveness and safety of modified posterior scleral reinforcement in Chinese children with high myopia

Qianru Ouyang,Zequn Miao,Xin Xu,Lili Guo,Qingyu Meng,Shuting Liang,Jingyi Zhang,Haoli Fu,Yu Cao,Lvzhen Huang,Lejin Wang

DOI: https://doi.org/10.21203/rs.3.rs-255754/v1

2021-01-01

Abstract:Abstract Background To evaluate the effectiveness and safety of modified posterior scleral reinforcement in controlling the progression of myopia in patients with high myopia and provide reference information on surgical treatment for these patients.Methods The study included 32 patients (55 eyes) with high myopia who were treated with modified posterior scleral reinforcement and were followed up at 3 months, 6 months, 1 year and 2 years after the operation.The axial length, refractive error, best corrected visual acuity (BCVA) and fundus colour photographs after the operation were compared with those before the operation, and whether there were any complications was recorded.Results The axial length of the eye increased by 0.07 mm, 0.12 mm, 0.31 mm and 0.19 mm at 3 months, 6 months, 1 year and 2 years after the operation, respectively. The refractive error increased by 0.05 D, 0.28 D, 0.53 D and 0.50 D at 3 months, 6 months, 1 year and 2 years after the operation, respectively, and the differences were not significant (P > 0.05). There were no statistically significant changes in BCVA, but there was an upward trend. No severe complications occurred.Conclusion Modified posterior scleral reinforcement can effectively delay the worsening of the ocular axis and refractive error, without severe complications in the short term.
The Efficacy and Safety of a Novel Posterior Scleral Reinforcement Device in Rabbits.

Yongguang Yuan,Yao Zong,Qishan Zheng,Garrett Qian,Xiaobin Qian,Yujie Li,Wanwen Shao,Qianying Gao

DOI: https://doi.org/10.1016/j.msec.2015.12.046

2016-01-01

Materials Science and Engineering C

Abstract:Purpose: To evaluate the efficacy and safety of posterior scleral reinforcement (PSR) device for myopia suppression in rabbits' eyes.Methods: PSR surgery was performed on the normal 12 8-week-old New Zealand white rabbits' right eyes. To determine efficacy of the device, ophthalmic examination would be taken at pre-operation and post-operation (1 week, 1 month, 3 months, 6 months, and 1 year), such as A-ultrasound, diopter and B-ultrasound. Evaluation of safety were based on the following indicators: intraocular pressure (DP), slit lamp, fundus photography, fundus fluorescein angiography and pathological examination after surgery. The efficacy and safety of PSR device were evaluated by comparison (treated eyes and contralateral eyes) of pre and post-operation.Results: The novel PSR device could significantly shorten axial length (preoperative axial length: 1636 +/- 0.14 mm, postoperative 1 week, 1 month, 3 months, 6 months and 1 year axial lengths: 15.03 +/- 0.28 mm, 15.23 +/- 0.32 mm, 15.39 +/- 0.31 mm, 15.45 +/- 0.22 mm and 15.45 +/- 0.22 mm; P = 0.00037 < 0.001) in the treated eyes (right eyes) after surgery. At different postoperative time points, the B-ultrasound images showed that the PSR located in appropriate position and supported the posterior sclera very well. At the same time, IOP of treated eyes kept a relatively stable level (preoperative IOP: 12.56 +/- 2.01 mmHg, postoperative IOP: ranging from 11.33 +/- 1.23 mmHg to 13.44 +/- 2.19 mmHg, P > 0.05) post-operation 1 year. During observation period, there was no significant inflammatory reaction and complications such as anterior chamber flare, empyema, endophthalmitis, vitreous hemorrhage, retina detachment and retinal choroid neovascularization by slit lamp, fundus photography and fundus fluorescein angiography. In addition, there were no pathologic changes be found by comparison treated eyes group and contralateral group eyes based on pathological examinations.Conclusions: In vivo study, effectively and safely, the novel PSR device can inhibit rabbits' axial length elongation during postoperative 1 year. This study demonstrates that this novel PSR could be a potential treatment approach for myopia. (C) 2016 The Authors. Published by Elsevier B.V.
Effects of posterior scleral reinforcement in pathological myopia: a 3-year follow-up study

Cheng Peng,Jun Xu,Xiangying Ding,Yuanyuan Lu,Jiao Zhang,Fang Wang,Jiaming Yu,Hongna Wang,Jinsong Zhang

DOI: https://doi.org/10.1007/s00417-018-04212-y

2018-12-15

Abstract:PurposeTo assess the effects of posterior sclera reinforcement (PSR) in refractive outcomes, choroidal thickness (CT), and retinal thickness (RT) during a 3-year follow-up in eyes with pathological myopia.MethodsThirty-eight eyes of 26 adults with pathological myopia who underwent PSR (the PSR group) and 30 eyes of 18 adults with matched age and myopia who did not receive PSR treatment (the control group) were followed up with measurements of axial length (AL), spherical equivalent (SE), best corrected visual acuity (BCVA), CT, and RT at baseline, 1 and 3 months, and 1, 2, and 3 years postoperatively. Data were analyzed by repeated measures analysis of variance and independent-samples t test.ResultsIn the PSR group, AL, SE, BCVA, and CT were tending to be relatively stable and no statistically significant changes were found during the follow-up (all P > 0.05). In contrast, in the control group, compared with the measurements taken at baseline, AL, SE, BCVA, and CT altered gradually from 1 month onward to 3 years postoperatively. At 2-year and 3-year follow-ups, significant differences in AL, SE, BCVA, and CT were noted between the PSR group and the control group (all P < 0.05). RTs of the center subfield and the inner ring were equal to the baseline in the control group; however, RTs of the center subfield at 1 year, 2 years, and 3 years postoperatively significantly slightly reduced compared with those at the baseline in the PSR group (all P < 0.05).ConclusionsThe effects of PSR in restraining eyeball elongation, stabilizing vision, and strengthening the structure of posterior pole are more prominent 2 years or more postoperatively compared with the natural progression of pathological myopia.
Early Safety and Biological Compatibility of a Bovine Pericardium Patch for Posterior Scleral Reinforcement

Ouyang Chaohu,Chu Renyuan,Zhao Mei,Chen Qian

DOI: https://doi.org/10.3760/cma.j.issn.1674-845x.2016.05.002

2016-01-01

Abstract:Objective To investigate the early safety and biological compatibility of a bovine pericardium patch for posterior scleral reinforcement (PSR).Methods This was a retrospective case series study.Three hundred seventy-seven consecutive cases (670 eyes) of patients with progressive axial myopia who received PSRs at Shanghai Peace Eye Hospital from January 2006 to October 2014 were divided into two groups based on the type of reinforcement:a bovine pericardium patch was used in 330 eyes (182 cases) and dura mater was used in 340 eyes (195 cases).The follow-up time was more than 6 months.All patients underwent routine eye examinations and retro-ocular examination was performed on some patients using high frequency B-scan.Data were analyzed with chi-square tests.Results The constituent ratios of improvement,unchanged BCVA or a decline in BCVA 6 months postoperatively were 31.8％ and 35.0％,63.3％ and 60.3％,and 4.8％ and 4.7％,respectively,for both groups.There were no significant differences between the two groups (x2=0.765,P＞0.05).The incidence of chemosis was 68.2％ and 75.9％,respectively,for the two groups (x2=4.935,P＜0.05).There was no evidence of infection,retinal detachment,intraocular hemorrhage,strabismus or diplopia in any patients.Rejection was observed in both eyes of one patient in the bovine pericardium patch group,and one eye of one patient in the dura mater group(incidences were 0.61％ and 0.29％,respectively,in Fisher's exact test,P＞0.05).Local calcification was observed in three of 28 eyes in the test group,but not in 19 eyes of the control group (Fisher's exact test,P＞0.05).Conclusion Bovine pericardium patch is safe and biologically compatible for PSR.
Posterior scleral reinforcement for the treatment of myopic traction maculopathy

Qing He,Xiu Wang,Qianhui Shi,Caiyuan Xie,Anquan Xue,Ruihua Wei

DOI: https://doi.org/10.1186/s12886-022-02497-6

2022-06-21

Abstract:Background: This study aimed to investigate the clinical effectiveness of posterior scleral reinforcement(PSR) for the treatment of myopic traction maculopathy (MTM). Methods: This was a prospective study of 32 eyes from 20 patients with MTM treated with PSR using genipin-cross-linked donor sclera. The length of the scleral strip used for the surgery was designed to be 1.5-times the axial length of the eye, whereas its width was 0.4-times the axial length of the eye. The optical coherence tomography images, spherical equivalent of refractive error, axial length, best corrected visual acuity, electroretinogram findings, and intraocular pressure of the patients were assessed postoperatively. Results: The mean duration of follow-up was 17.80 ± 8.74 months. The differences between the spherical equivalent of refractive error, best corrected visual acuity, axial length, and electroretinogram findings recorded preoperatively and those measured postoperatively were statistically significant (p < 0.05). The final reduction in axial length was 1.64 ± 0.85 mm. At the end of the follow-up, optical coherence tomography showed essential foveal reattachment in 30 eyes (93.75%), partial reattachment in two eyes (6.25%), and closure of macular holes in seven eyes (77.78%). No retinal detachment, vitreous haemorrhage, or other serious complications occurred following the surgery. Conclusions: Posterior scleral reinforcement with genipin-cross-linked sclera showed safe and effective outcomes for the treatment of MTM during a follow-up period of at least one year. Trial registration: 11\12\2018, ChiCTR1800020012 .
Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report

Chunxiao Yan,Fangkun Zhao,Shang Gao,Xiaoyu Liu,Taorui Yu,Yanan Mu,Lijun Zhang,Jun Xu

DOI: https://doi.org/10.1186/s12886-023-03211-w

2023-11-28

Abstract:Background: Myopia has recently emerged as a significant threat to global public health. The high and pathological myopia in children and adolescents could result in irreversible damage to eye tissues and severe impairment of visual function without timely control. Posterior scleral reinforcement (PSR) can effectively control the progression of high myopia by limiting posterior scleral expansion, improving retrobulbar vascular perfusion, thereby stabilizing the axial length and refraction of the eye. Moreover, orthokeratology and low concentrations of atropine are also effective in slowing myopia progression. Case presentation: A female child was diagnosed with binocular congenital myopia and amblyopia at the age of 3 and the patient's vision had never been rectified with spectacles at the first consultation. The patient's ophthalmological findings suggested, high refractive error with low best corrected visual acuity, longer axial length beyond the standard level of her age, and fundus examination suggesting posterior scleral staphyloma with weakened hemodynamics of the posterior ciliary artery. Thereby, PSR was performed to improve fundus health and the combination of orthokeratology and 0.01% atropine were performed to control the development of myopia. Following up to 8 years of clinical treatment and observations, the progression of myopia could be well controlled and fundus health was stable. Conclusion: In this report, 8-year of clinical observation indicated that PSR could improve choroidal thickness and hemodynamic parameters of the retrobulbar vessels, postoperative orthokeratology combined with 0.01% atropine treatment strategy may be a good choice for myopia control effectively.
Investigation of Macular Choroidal Thickness and Blood Flow Change by Optical Coherence Tomography Angiography After Posterior Scleral Reinforcement

Zheng Zhang,Yue Qi,Wenbin Wei,Zi-Bing Jin,Wen Wang,Anli Duan,Wu Liu

DOI: https://doi.org/10.3389/fmed.2021.658259

IF: 3.9

2021-04-29

Frontiers in Medicine

Abstract:Purpose: This work aimed to study the effect of posterior scleral reinforcement (PSR) on choroidal thickness (CT) and blood flow. Methods: This study included 25 eyes of 24 patients with high myopia ( ≤ -6.0 dioptres or axial length ≥ 26.0 mm) who underwent PSR surgery. All patients completed the 1-month follow-up visit. Myopic macular degeneration (MMD) was graded according to the International Meta-Analysis for Pathologic Myopia (META-PM) classification based on color fundus photographs. Swept-source optical coherence tomography angiography (SSOCTA) was performed to investigate CT, choroidal perfusion area (CPA), and choriocapillaris perfusion area (CCPA) change following PSR surgery. Results: The distribution of MMD categories was 9 (36.0%) in category 1, 10 (40.0%) in category 2, and 6 (24.0%) in category 3 or 4. MMD severity was strongly correlated with CT (all P < 0.01) and CPA (all P < 0.04). Postoperative CT at each sector increased significantly at 1 week's follow-up, compared to preoperative measures (all P < 0.05). Postoperative CPA at subfoveal, superior, inferior, and nasal sectors also increased significantly 1 week after PSR surgery (all P < 0.05). Moreover, the increased CT, CPA, and CCPA remain after PSR surgery at 1 month's follow-up, but the difference was not statistically significant. Conclusions: We demonstrated that the CT and choroidal blood flow increased significantly in patients with high myopia who underwent PSR surgery in a short period of time. In addition, the CT and CPA were independently associated with MMD. However, whether the transient improvement of the choroidal circulation could prevent long-term progression of high myopia warrants further study in the future.

medicine, general & internal
[Long-Term Studies on Clinical Therapeutic Efficiency of Posterior Scleral Reinforcement Surgery].

Xiu-duo Liu,Jia-hua Lü,Ren-yuan Chu

DOI: https://doi.org/10.3760/cma.j.issn.0412-4081.2011.06.010

2011-01-01

Abstract:OBJECTIVE:To assess the safety and efficiency of posterior scleral reinforcement surgery by analyzing data collected for more than ten years after the surgery.METHODS:Sixteen patients (32 eyes) with high myopia who underwent scleral reinforcement were followed up for more than ten years (10 to 13 years).RESULTS:Best corrected visual acuity was stable (t = 0.26, P > 0.05). The average axial elongation was 0.056 mm per year postoperation after surgery. The ratio of choroidal neovascularization in the operation group was 3.1% (1/32).CONCLUSIONS:Posterior scleral reinforcement is a safe and effective. This procedure can prevent the development of choroidal neovascularization in high myopia. A control study with a larger group of cases as well as related basic is still required.
Posterior scleral reinforcement on progressive high myopic young patients

Anquan Xue,Fangjun Bao,Linyan Zheng,Qinmei Wang,Lingyun Cheng,Jia Qu

DOI: https://doi.org/10.1097/OPX.0000000000000201

Abstract:Purpose: To evaluate the effect of posterior scleral reinforcement in controlling high myopic axial progression in young patients. Methods: Only one eye of each patient had posterior scleral reinforcement surgery. Before surgery and at each postoperative follow-up, the best corrected visual acuity, intraocular pressure, refractive errors, indirect ophthalmoscopy, B-type ultrasonography, and IOLMASTER reflected light biometry were performed on both eyes. The changes of axial length and the changes of refractive errors from the baseline were compared between the surgery eyes and the contralateral eyes. Results: Thirty patients had a mean age of 7.5 years and a mean spherical equivalent of -9.72 diopters. The mean elongation of axial length was significantly less in the surgery eye group than that in the contralateral eye group (0.75 mm vs. 0.94 mm, p < 0.0001, paired t test) after a mean follow-up of 895 days. The surgical effect was mild but maintained during the follow-up. The eyes with staphyloma gained less surgical effect when compared with the eyes without staphyloma (p = 0.0036). There was also a notable nonstatistically significant trend for younger patients to gain a larger surgical effect (p = 0.0986). Conclusions: Posterior scleral reinforcement surgery was found effective in slowing down high myopic axial progression in young patients within the study period, but the size of the effect was small. The surgical procedure is well tolerated without vision-threatening complications.
An Experimental Study on Collagen Content and Biomechanical Properties of Sclera after Posterior Sclera Reinforcement

Chen Weiyi,Wang Xiaojun,Wang Chaoying,Li Tao,Li Xiaona,Zhang Quanyou

DOI: https://doi.org/10.1016/j.clinbiomech.2007.10.013

2007-01-01

Abstract:Background The development of pathological myopia is associated with reduced scleral collagen accumulation, scleral thinning, and loss of scleral tissue, in both humans and animal models. Posterior scleral reinforcement (PSR) was considered as an effective way for treating pathological myopia. Yet it is not well understood the possible role of collagen on the sclera reinforcement mechanisms in the PSR surgery. Methods PSR surgery was performed on the normal adult New Zealand white rabbits eyes. Human sclera was used as reinforcement materials. At 1, 2, 3, 6, 9 months after the PSR surgery, scleral hydroxyproline (Hyp) synthesis and collagen fibers arrangement were determined by enzymolysic hydrolysis assay and histological morphology technique. An Instron test machine was used to investigate the elastic modulus of sclera. Findings It was found that the elastic modulus and Hyp content of reinforced sclera were lower at first month after surgery, and then gradually up to physiological level in the following months. Those two indexes were close to that of the normal control groups at 9 months. Interpretation These findings indicate that sclera elastic modulus was associated with both change of Hyp content and collagen fibers arrangement after PSR. The therapeutic effect of PSR surgery was confirmed not only from biological but also biomechanical aspects.
Biomechanical Considerations of Patching Material for Posterior Scleral Reinforcement Surgery

Jinlei Ma,Fangyuan Wu,Zhiyong Liu,Yijiong Fang,Xu Chu,Linyan Zheng,Anquan Xue,Kaihui Nan,Jia Qu,Lingyun Cheng

DOI: https://doi.org/10.3389/fmed.2022.888542

2022-05-16

Abstract:Purpose: To characterize biomechanical properties of genipin-crosslinked human dura mater as reinforcing material for posterior scleral reinforcement (PSR) and to compare it with crosslinked human sclera. Methods: Donor dura mater and sclera were crosslinked in the same optimized genipin solution. Resistance to enzyme degradation for both materials were investigated by exposing the materials to accelerated enzyme degrading. Elastic modulus and tensile strength were measured by biomechanics testing equipment. Crosslinked human dura mater was used as reinforcing patch in PSR on 57 adult pathologic myopic eyes. The patients were followed up for an average 3 years. The main outcome was eye globe axial length change and safety profile of the reinforcing material. Results: Crosslinked dura mater demonstrated similar percentage weight loss to crosslinked sclera when exposed to enzymatic solution. Dura mater has higher density than sclera. The retaining elastic modulus after enzyme exposure was 72.02 MPa for crosslinked dura mater while 53.88 MPa for crosslinked sclera, 34% greater for crosslinked dura mater, P = 0.0186). At the end of 3 years follow-up, the mean globe axis of the surgery eyes was reduced by 1.29 mm (from 30.81 to 29.51 mm, P < 0.0001, paired t-test). Visual acuity (BCVA logMar) improved by 0.10 logMar unit which is an improvement of five letters (P = 0.0184, paired t-test). No material specific complication was noted. Conclusion: Crosslinked human dura mater may be superior to crosslinked human sclera as reinforcing material for PSR to manage progression of high myopia. This material was well tolerated on human eye.

Posterior Scleral Reinforcement Combined with Patching Therapy for Pre-School Children with Unilateral High Myopia

The efficacy of modified posterior scleral reinforcement with round scleral patches in Chinese children with high myopia

Efficacy of Posterior Scleral Reinforcement in Treating Anisometropic Amblyopia Associated With Unilateral High Myopia in Children

Modified Posterior Scleral Reinforcement As a Treatment for High Myopia in Children and Its Therapeutic Effect

Clinical outcomes of posterior scleral reinforcement in Chinese high myopia children

The Efficacy and Safety of Modified Snyder–Thompson Posterior Scleral Reinforcement in Extensive High Myopia of Chinese Children

Curative effects of posterior scleral reinforce-ment in high myopic patients with macular retinoschisis

Effect and safety posterior scleral reinforcement on controlling myopia in children: a meta-analysis

Posterior Scleral Reinforcement in the Treatment of Macular Retinoschisis in Highly Myopic Patients

Security and validity of posterior sclera reinforcement for high myopic retinopathy

The effectiveness and safety of modified posterior scleral reinforcement in Chinese children with high myopia

The Efficacy and Safety of a Novel Posterior Scleral Reinforcement Device in Rabbits.

Effects of posterior scleral reinforcement in pathological myopia: a 3-year follow-up study

Early Safety and Biological Compatibility of a Bovine Pericardium Patch for Posterior Scleral Reinforcement

Posterior scleral reinforcement for the treatment of myopic traction maculopathy

Observation of the effect of posterior scleral reinforcement combined with orthokeratology and 0.01% atropine in the treatment of congenital myopia: a case report

Investigation of Macular Choroidal Thickness and Blood Flow Change by Optical Coherence Tomography Angiography After Posterior Scleral Reinforcement

[Long-Term Studies on Clinical Therapeutic Efficiency of Posterior Scleral Reinforcement Surgery].

Posterior scleral reinforcement on progressive high myopic young patients

An Experimental Study on Collagen Content and Biomechanical Properties of Sclera after Posterior Sclera Reinforcement

Biomechanical Considerations of Patching Material for Posterior Scleral Reinforcement Surgery